CompaniesKrystal Biotech
Krystal Biotech logo

Krystal Biotech

active
Pittsburgh, PA, United States
Founded 2015
Website
About

Gene Therapy

Areas of Focus

Categories

Gene Therapy, RNA & Peptide TherapyNJ, NY, PA
Team (15)
Catherine MazzaccoBoard Member
Catherine MazzaccoBoard Member
Krystal Biotech
team_member
Chris MasonBoard Member
Chris MasonBoard Member
Krystal Biotech
team_member
Dan JanneyBoard Member
Dan JanneyBoard Member
Krystal Biotech
team_member
David ChienSVP, Clinical Development
David ChienSVP, Clinical Development
Krystal Biotech
team_member
Dino A. RossiBoard Member
Dino A. RossiBoard Member
Krystal Biotech
team_member
Felino ObilloVP, Global Supply Chain
Felino ObilloVP, Global Supply Chain
Krystal Biotech
team_member
View all 15 team members →
Clinical Trials (18)
View all

Total Trials

18

As Lead Sponsor

18

As Collaborator

0

Total Enrollment

851

By Phase

PHASE3: 3PHASE1/PHASE2: 7PHASE1: 4PHASE2: 1

By Status

RECRUITING: 8COMPLETED: 4ACTIVE_NOT_RECRUITING: 2UNKNOWN: 2WITHDRAWN: 2
Clinical Trials Pipeline18 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
Today
NCT01837862
NCT04047732
NCT04540900
NCT04917887
NCT05970497
NCT06049082
NCT06228326
Hover over trial bars to see details

Recent Trials

NCT07016750Lead Sponsor
A Study Assessing KB803 Compared to Matching Placebo for the Treatment and Prevention of Corneal Abrasions in Dystrophic Epidermolysis Bullosa
PHASE3Recruiting
16 participants
Started: Jun 20, 2025 · Completed: Mar 31, 2026
NCT06999733Lead Sponsor
A Study Assessing KB801 for the Treatment of Stage 2 or 3 Neurotrophic Keratitis
PHASE1/PHASE2Recruiting
27 participants
Started: May 31, 2025 · Completed: Oct 31, 2026
NCT06724900Lead Sponsor
A Study Assessing KB304 for the Treatment of Wrinkles in Women
PHASE1/PHASE2Active, not recruiting
19 participants
Started: Nov 20, 2024 · Completed: Aug 31, 2025
NCT06563414Lead Sponsor
A Natural History Study of Corneal Abrasions in Patients With Dystrophic Epidermolysis Bullosa (DEB)
N/ARecruiting
40 participants
Started: Aug 2, 2024 · Completed: Dec 31, 2025
NCT06228326Lead Sponsor
A Study Assessing KB707 for the Treatment of Advanced Solid Tumor Malignancies Affecting the Lungs
PHASE1/PHASE2Recruiting
200 participants
Started: Apr 17, 2024 · Completed: Feb 29, 2028
View all 18 trials →
Funding History (20)
8-K
Aug 4, 2025
Filing
8-K
Jul 25, 2025
Filing
8-K
Jul 24, 2025
Filing
8-K
Jul 9, 2025
Filing
8-K
Jun 2, 2025
Filing
8-K
May 19, 2025
Filing
8-K
May 13, 2025
Filing
8-K
May 6, 2025
Filing
8-K
May 6, 2025
Filing
8-K
Apr 28, 2025
Filing
Locations (1)
Headquarters
Pittsburgh, PA, United States
Map

Loading map...